Radiation-induced small bowel disease: Latest developments and clinical guidance

Therapeutic Advances in Chronic Disease

Volumn 5, Issue 1, 2014, Pages 15-29

  Stacey, Rhodri ^a   Green, John T ^a  

^a LLANDOUGH HOSPITAL   (United Kingdom)

Author keywords

Chronic radiation enteritis; Pelvic radiation disease; Radiation enteritis treatment; Radiation enteropathy

Indexed keywords

AMIFOSTINE; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; ATROPINE; CIPROFLOXACIN; COLESEVELAM; COLESTYRAMINE; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOPERAMIDE; MESALAZINE; METHYLPREDNISOLONE; OCTREOTIDE; PENTOXIFYLLINE; PROBIOTIC AGENT; RIFAXIMIN; SALAZOSULFAPYRIDINE; SUCRALFATE; TEDUGLUTIDE; TETRACYCLINE; TOCOPHEROL;

CANCER RADIOTHERAPY; CIRCADIAN RHYTHM; CLINICAL ASSESSMENT; DIARRHEA; DIET SUPPLEMENTATION; DISEASE SEVERITY; HUMAN; HYPERBARIC OXYGEN; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; INTENSITY MODULATED RADIATION THERAPY; MALABSORPTION; NONHUMAN; NUTRITIONAL ASSESSMENT; OXIDATIVE STRESS; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; WOUND HEALING;

EID: 84898887052     PISSN: 20406223     EISSN: 20406231     Source Type: Journal    
DOI: 10.1177/2040622313510730     Document Type: Review

References (111)

1. Ahmad S. Duke S. Jena R. Williams M. Burnet N. (2012) Advances in radiotherapy. BMJ (Clin Res Ed) 345: e7765.
2. Andersson H. Bosaeus I. Nystrom C. (1978) Bile salt malabsorption in the radiation syndrome. Acta Radiologica 17: 312–318.
3. Andreyev H. (2007 a) Gastrointestinal problems after pelvic radiotherapy: the past, the present and the future. Clin Oncol 19: 790–799.
4. Andreyev H. (2007 b) Gastrointestinal symptoms after pelvic radiotherapy: a new understanding to improve management of symptomatic patients. Lancet Oncol 8: 1007–1017.
5. Andreyev H. Amin Z. Blake P. Dearnaley D. Tait D. Vlavianos P. (2003) GI symptoms developing after pelvic radiotherapy require gastroenterological review but is that happening in the UK? Clin Oncol 15: S12 (abstract).
6. Andreyev H. Davidson S. Gillespie C. Allum W. Swarbrick E. for the British Society of Gastroenterology, Association of Colo-Proctology of Great Britain and Ireland (2012) Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer. Gut 61: 179–192.
7. Andreyev H. Vlavianos P. Blake P. Dearnaley D. Norman A. Tait D. (2005) Gastrointestinal symptoms after pelvic radiotherapy: role for the gastroenterologist? Int J Radiation Oncol Biol Phys 62: 1464–1471.
8. Arlow F. Dekovich A. Priest R. Beher W. (1987) Bile acids in radiation-induced diarrhea. Southern Med J 80: 1259–1261.
9. Athanassiou H. Antonadou D. Coliarakis N. Kouveli A. Synodinou M. Paraskevaidis M. et al. (2003) Protective effect of amifostine during fractionated radiotherapy in patients with pelvic carcinomas: results of a randomized trial. Int J Radiat Oncol Biol Phys 56: 1154–1160.
10. Beer W. Fan A. Halsted C. (1985) Clinical and nutritional implications of radiation enteritis. Am J Clin Nutr 41: 85–91.
11. Beitler A. Rodriguez-Bigas M. Weber T. Lee R. Cuenca R. Petrelli N. (1997) Complications of absorbable pelvic mesh slings following surgery for rectal carcinoma. Dis Colon Rectum 40: 1336–1341.
12. Ben-Josef E. Han S. Tobi M. Shaw L. Bonner H. Vargas B. et al. (2002) A pilot study of topical intrarectal application of amifostine for prevention of late radiation rectal injury. Int J Radiat Oncol Biol Phys 53: 1160–1164.
13. Bennett M. Feldmeier J. Hampson N. Smee R. Milross C. (2012) Hyperbaric oxygen therapy for late radiation tissue injury. Cochrane Database Syst Rev 5: CD005005.
14. Berthrong M. (1986) Pathologic changes secondary to radiation. World J Surg 10: 155–170.
15. Board of the Faculty of Clinical Oncology of the Royal College of Radiologists (2006) Radiotherapy dose–fractionation. Royal College of Radiologists, London. Available at http://www.rcr.ac.uk/docs/oncology/pdf/Dose-Fractionation_Final.pdf
16. Booth C. Booth D. Williamson S. Demchyshyn L. Potten C. (2004) Teduglutide ([Gly2]GLP-2) protects small intestinal stem cells from radiation damage. Cell Proliferation 37: 385–400.
17. Bouhnik Y. Alain S. Attar A. Flourié B. Raskine L. Sanson-Le Pors M. et al. (1999) Bacterial populations contaminating the upper gut in patients with small intestinal bacterial overgrowth syndrome. Am J Gastroenterol 94: 1327–1331.
18. Buchi K. Moore J. Hrushesky W. Sothern R. Rubin N. (1991) Circadian rhythm of cellular proliferation in the human rectal mucosa. Gastroenterology 101: 410–415.
19. Bye A. Kaasa S. Ose T. Sundfør K. Tropé C. (1992) The influence of low fat, low lactose diet on diarrhoea during pelvic radiotherapy. Clin Nutrition 11: 147–153.
20. Chitapanarux I. Chitapanarux T. Traisathit P. Kudumpee S. Tharavichitkul E. Lorvidhaya V. (2010) Randomized controlled trial of live lactobacillus acidophilus plus bifidobacterium bifidum in prophylaxis of diarrhea during radiotherapy in cervical cancer patients. Radiat Oncol 5: 31.
21. Crook J. Esche B. Futter N. (1996) Effect of pelvic radiotherapy for prostate cancer on bowel, bladder, and sexual function: the patient's perspective. URL 47: 387–394.
22. Czito B. Willett C. (2010) Radiation injury. In Ed. Feldman M. Lawrence S. Friedman L. Brandt L. (eds), Sleisenger and Fordtran's Gastrointestinal and Liver Disease. Pathophysiology, Diagnosis, Management (9th edn). Philadelphia, PA: Saunders.
23. Danielsson A. Nyhlin H. Persson H. Stendahl U. Stenling R. Suhr O. (1991) Chronic diarrhoea after radiotherapy for gynaecological cancer: occurrence and aetiology. Gut 32: 1180–1187.
24. Dasmahapatra K. Swaminathan A. (1991) The use of a biodegradable mesh to prevent radiation-associated small-bowel injury. Arch Surg 126: 366–369.
25. Delia P. Sansotta G. Donato V. Frosina P. Messina G. de Renzis C. et al. (2007) Use of probiotics for prevention of radiation-induced diarrhea. World J Gastroenterol 13: 912–915.
26. Denham J. Hauer-Jensen M. (2002) The radiotherapeutic injury–a complex ‘wound’. Radiother Oncol 63: 129–145.
27. Denton A. Forbes A. Andreyev J. Maher E. (2002) Non surgical interventions for late radiation proctitis in patients who have received radical radiotherapy to the pelvis. Cochrane Database Syst Rev 1: CD003455.
28. Devereux D. Chandler J. Eisenstat T. Zinkin L. (1988) Efficacy of an absorbable mesh in keeping the small bowel out of the human pelvis following surgery. Dis Colon Rectum 31: 17–21.
29. Devereux D. Kavanah M. Feldman M. Kondi E. Hull D. O'Brien M. et al. (1984) Small bowel exclusion from the pelvis by a polyglycolic acid mesh sling. J Surg Oncol 26: 107–112.
30. Do N. Nagle D. Poylin V. (2011) Radiation proctitis: current strategies in management. Gastroenterol Res Practice 2011: 917941.
31. Empey L. Papp J. Jewell L. Fedorak R. (1992) Mucosal protective effects of vitamin E and misoprostol during acute radiation-induced enteritis in rats. Digest Dis Sci 37: 205–214.
32. Feldmeier J. Hampson N. (2002) A systematic review of the literature reporting the application of hyperbaric oxygen prevention and treatment of delayed radiation injuries: an evidence based approach. Undersea Hyperbaric Med 29: 4–30.
33. Felemovicius I. Bonsack M. Baptista M. Delaney J. (1995) Intestinal radioprotection by vitamin E (alpha-tocopherol). Ann Surg 222: 504–510.
34. Galland R. Spencer J. (1986) Surgical management of radiation enteritis. Surgery 99: 133–139.
35. Gami B. Harrington K. Blake P. Dearnaley D. Tait D. Davies J. et al. (2003) How patients manage gastrointestinal symptoms after pelvic radiotherapy. Aliment Pharmacol Therapeut 18 (10), pp. 987–994.
36. Gaugler M. Vereycken-Holler V. Squiban C. Vandamme M. Vozenin-Brotons M. Benderitter M. (2005) Pravastatin limits endothelial activation after irradiation and decreases the resulting inflammatory and thrombotic responses. Radiation Res 163 (5), pp. 479–487.
37. Gavazzi C. Bhoori S. Lovullo S. Cozzi G. Mariani L. (2006) Role of home parenteral nutrition in chronic radiation enteritis. Am J Gastroenterol 101: 374–379.
38. Gibson R. Keefe D. Lalla R. Bateman E. Blijlevens N. Fijlstra M. et al. (2013) Systematic review of agents for the management of gastrointestinal mucositis in cancer patients. Supportive Care Cancer 21: 313–326.
39. Giralt J. Regadera J. Verges R. Romero J. de la Fuente I. Biete A. et al. (2008) Effects of probiotic Lactobacillus casei DN-114 001 in prevention of radiation-induced diarrhea: results from multicenter, randomized, placebo-controlled nutritional trial. Int J Radiat Oncol Biol Phys 71: 1213–1219.
40. Goldstein F. Khoury J. Thornton J. (1976) Treatment of chronic radiation enteritis and colitis with salicylazosulfapyridine and systemic corticosteroids. A pilot study. Am J Gastroenterol 65: 201–208
41. Gothard L. Cornes P. Brooker S. Earl J. Glees J. Hall E. Peckitt C. et al. (2005) Phase II study of vitamin E and pentoxifylline in patients with late side effects of pelvic radiotherapy. Radiother Oncol 75: 334–341.
42. Guerrero Urbano M. Henrys A. Adams E. Norman A. Bedford J. Harrington K. et al. (2006) Intensity-modulated radiotherapy in patients with locally advanced rectal cancer reduces volume of bowel treated to high dose levels. Int J Radiat Oncol Biol Phys 65: 907–916.
43. Hamama S. Delanian S. Monceau V. Vozenin M. (2012) Therapeutic management of intestinal fibrosis induced by radiation therapy: from molecular profiling to new intervention strategies et vice et versa. Fibrogenesis Tissue Repair 5(Suppl. 1): S13.
44. Harris V. Benton B. Sohaib A. Dearnaley D. Andreyev H. (2012) Bile acid malabsorption after pelvic and prostate intensity modulated radiation therapy: an uncommon but treatable condition. Int J Radiat Oncol Biol Phys 84: 601–606.
45. Haruta H. Yamamoto H. Mizuta K. Kita Y. Uno T. Egami S. et al. (2005) A case of successful enteroscopic balloon dilation for late anastomotic stricture of choledochojejunostomy after living donor liver transplantation. Liver Transplantation 11: 1608–1610.
46. Haydont V. Bourgier C. Pocard M. Lusinchi A. Aigueperse J. Mathé D. et al. (2007) Pravastatin Inhibits the Rho/CCN2/extracellular matrix cascade in human fibrosis explants and improves radiation-induced intestinal fibrosis in rats. Clinical Cancer Res 13: 5331–5340.
47. Haydont V. Mathé D. Bourgier C. Abdelali J. Aigueperse J. Bourhis J. et al. (2005) Induction of CTGF by TGF-beta1 in normal and radiation enteritis human smooth muscle cells: Smad / Rho balance and therapeutic perspectives. Radiother Oncol 76: 219–225.
48. Hille A. Christiansen H. Pradier O. Hermann R. Siekmeyer B. Weiss E. et al. (2005) Effect of pentoxifylline and tocopherol on radiation proctitis/enteritis. Strahlenther Onkol 181: 606–614.
49. Husebye E. Skar V. Høverstad T. Iversen T. Melby K. (1995) Abnormal intestinal motor patterns explain enteric colonization with gram-negative bacilli in late radiation enteropathy. Gastroenterology 109: 1078–1089.
50. Ijiri K. Potten C. (1988) Circadian rhythms in the incidence of apoptotic cells and number of clonogenic cells in intestinal crypts after radiation using normal and reversed light conditions. Int J Radiat Biol Relat Stud Phys Chem Med 53: 717–727.
51. Ijiri K. Potten C. (1990) The circadian rhythm for the number and sensitivity of radiation-induced apoptosis in the crypts of mouse small intestine. Int J Radiat Biol 58: 165–175.
52. Jao S. Beart R. Gunderson L. (1986) Surgical treatment of radiation injuries of the colon and rectum. Am J Surg 151: 272–277.
53. Jha N. Harris J. Seikaly H. Jacobs J. McEwan A. Robbins K. et al. (2012) A phase II study of submandibular gland transfer prior to radiation for prevention of radiation-induced xerostomia in head-and-neck cancer (RTOG 0244). Int J Radiat Oncol Biol Phys 84: 437–442.
54. Kamal-Bahl S. Burke T. Watson D. Wentworth C. (2007) Discontinuation of lipid modifying drugs among commercially insured United States patients in recent clinical practice. Am J Cardiol 99: 530–534.
55. Kavanah M. Feldman M. Devereux D. Kondi E. (1985) New surgical approach to minimize radiation-associated small bowel injury in patients with pelvic malignancies requiring surgery and high-dose irradiation. A preliminary report. Cancer 56: 1300–1304.
56. Kennedy G. Heise C. (2005) Radiation colitis and proctitis. Clin Colon Rectal Surg 20: 64–72.
57. Khalid U. McGough C. Hackett C. Blake P. Harrington K. Khoo V. et al. (2006) A modified inflammatory bowel disease questionnaire and the Vaizey Incontinence questionnaire are more sensitive measures of acute gastrointestinal toxicity during pelvic radiotherapy than RTOG grading. Int J Radiat Oncol Biol Phys 64: 1432–1441.
58. Kita H. Yamamoto H. Yano T. Miyata T. Iwamoto M. Sunada K. et al. (2007) Double balloon endoscopy in two hundred fifty cases for the diagnosis and treatment of small intestinal disorders. Inflammopharmacology 15 (2): 74–77.
59. Kligler B. Cohrssen A. (2008) Probiotics. Am Fam Physician 78: 1073–1078.
60. Kountouras J. Zavos C. (2008) Recent advances in the management of radiation colitis. World J Gastroenterol 14: 7289–7301.
61. Kozelsky T. Meyers G. Sloan J. Shanahan T. Dick S. Moore R. et al. (2003) Phase III double-blind study of glutamine versus placebo for the prevention of acute diarrhea in patients receiving pelvic radiation therapy. J Clin Oncol 21: 1669–1674.
62. Lange M. Marijnen C. Maas C. Putter H. Rutten H. Stiggelbout A. et al. (2009) Risk factors for sexual dysfunction after rectal cancer treatment. Eur J Cancer 45: 1578–1588.
63. Leiper K. Morris A. (2007) Treatment of radiation proctitis. Clin Oncol 19: 724–729.
64. Leonard C. Shapiro H. Henkenberns Cornish P. Dahl K. (2005) Amifostine used as a normal tissue protectant in patients receiving pelvic radiotherapy. Int J Radiat Oncol Biol Phys 63: S448.
65. Loiudice T. Lang J. (1983) Treatment of radiation enteritis: a comparison study. Am J Gastroenterol 78: 481–487.
66. Ludgate S. Merrick M. (1985) The pathogenesis of post-irradiation chronic diarrhoea: measurement of SeHCAT and B 12 absorption for differential diagnosis determines treatment. Clin Radiol 36: 275–278.
67. Luna-Pérez P. Rodríguez-Ramírez S. Vega J. Sandoval E. Labastida S. (2001) Morbidity and mortality following abdominoperineal resection for low rectal adenocarcinoma. Rev Investigación Clínica 53: 388–395.
68. Martenson J. Bollinger J. Sloan J. Novotny P. Urias R. Michalak J. et al. (2000) Sucralfate in the prevention of treatment-induced diarrhea in patients receiving pelvic radiation therapy: A North Central Cancer Treatment Group phase III double-blind placebo-controlled trial. J Clin Oncol 18: 1239–1245.
69. McGinley P. Powell W. Bostwick J. (1980) Dosimetry of a silicone breast prosthesis. Radiology 135: 223–224.
70. Mundt A. Roeske J. Lujan A. (2002) Intensity-modulated radiation therapy in gynecologic malignancies. Med Dosimetry 27: 131–136.
71. Mutlu-Türkoğlu U. Erbil Y. Oztezcan S. Olgaç V. Toker G. Uysal M. (2000) The effect of selenium and / or vitamin E treatments on radiation-induced intestinal injury in rats. Life Sci 66: 1905–1913.
72. National Cancer Institute (2012) PDQ® Gastrointestinal Complications. Bethesda, MD: National Cancer Institute. Available at: http://cancer.gov/cancertopics/pdq/supportivecare/gastrointestinalcomplications/HealthProfessional (last modified 18 July 2012).
73. Nguyen B. Hamper U. (1997) Pelvic silicone prosthesis for prevention of radiation enteritis: US and CT features. Abdominal Imaging 22: 175–177.
74. Nutting C. Convery D. Cosgrove V. Rowbottom C. Padhani A. Webb S. et al. (2000) Reduction of small and large bowel irradiation using an optimized intensity-modulated pelvic radiotherapy technique in patients with prostate cancer. Int J Radiat Oncol Biol Phys 48: 649–656.
75. Olopade F. Norman A. Blake P. Dearnaley D. Harrington K. Khoo V. et al. (2005) A modified Inflammatory Bowel Disease questionnaire and the Vaizey Incontinence questionnaire are simple ways to identify patients with significant gastrointestinal symptoms after pelvic radiotherapy. Br J Cancer 92: 1663–1670.
76. Onodera H. Nagayama S. Mori A. Fujimoto A. Tachibana T. Yonenaga Y. (2005) Reappraisal of surgical treatment for radiation enteritis. World J Surg 29: 459–463.
77. Ostrau C. Hülsenbeck J. Herzog M. Schad A. Torzewski M. Lackner K. et al. (2009) Lovastatin attenuates ionizing radiation-induced normal tissue damage in vivo. Radiother Oncol 92: 492–499.
78. Pasha S. Harrison M. Leighton J. (2007) Obscure GI bleeding secondary to radiation enteritis diagnosed and successfully treated with retrograde double-balloon enteroscopy. Gastrointest Endosc 65: 552–554.
79. Portelance L. Chao K. Grigsby P. Bennet H. Low D. (2001) Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation. Int J Radiat Oncol Biol Phys 51: 261–266.
80. Puleston J. Morgan H. Andreyev J. (2005) New treatment for bile salt malabsorption. Gut 54: 441–442.
81. Quigley E. Abu-Shanab A. (2010) Small intestinal bacterial overgrowth. Infect Dis Clin N Am 24: 943–959.
82. Quigley E. Quera R. (2006) Small intestinal bacterial overgrowth: roles of antibiotics, prebiotics, and probiotics. Gastroenterology 130(2 Suppl. 1): S78–S90.
83. Randall M. Ibbott G. (2006) Intensity-modulated radiation therapy for gynecologic cancers: pitfalls, hazards, and cautions to be considered. Sem Radiat Oncol 16: 138–143.
84. Rodier J. Janser J. Rodier D. Dauplat J. Kauffmann P. Le Bouedec G. et al. (1991) Prevention of radiation enteritis by an absorbable polyglycolic acid mesh sling. A 60-case multicentric study. Cancer 68: 2545–2549.
85. Roeske J. Lujan A. Rotmensch J. Waggoner S. Yamada D. Mundt A. (2000) Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies. Int J Radiat Oncol Biol Phys 48: 1613–1621.
86. Salminen E. Elomaa I. Minkkinen J. Vapaatalo H. Salminen S. (1988) Preservation of intestinal integrity during radiotherapy using live Lactobacillus acidophilis cultures. Clin Radiol 39: 435–437.
87. Scolapio J. Fleming C. Kelly D. Wick D. Zinsmeister A. (1999) Survival of home parenteral nutrition-treated patients: 20 years of experience at the Mayo Clinic. Mayo Clinic Proc 74: 217–222.
88. Scolapio J. Ukleja A. Burnes J. Kelly D. (2002) Outcome of patients with radiation enteritis treated with home parenteral nutrition. Am J Gastroenterol 97: 662–666.
89. Sekhon S. (2000) Chronic radiation enteritis Women's food tolerances after radiation treatment for gynecologic cancer. J Am Dietetic Assoc 100: 941–943.
90. Sener S. Imperato J. Blum M. Ignatoff J. Soper T. Winchester D. et al. (1989) Technique and complications of reconstruction of the pelvic floor with polyglactin mesh. Surg Gynecol Obstetrics 168: 475–480.
91. Sezeur A. Abbou C. Chopin D. Rey P. Leandri J. (1990) Protection of the small intestine against irradiation by means of a removable prosthesis. ASAIO Trans 36 (3): M681–M683.
92. Shukla P. Gupta D. Bisht S. Pant M. Bhatt M. Gupta R. et al. (2010) Circadian variation in radiation-induced intestinal mucositis in patients with cervical carcinoma. Cancer 116: 2031–2035.
93. Silvain C. Besson I. Ingrand P. Beau P. Fort E. Matuchansky C. et al. (1992) Long-term outcome of severe radiation enteritis treated by total parenteral nutrition. Dig Dis Sci 37: 1065–1071.
94. Smith T. Micklewright A. Hirst A. Stratton R. Baxter J. (2011) Annual BANS Report, 2011 artificial nutrition support in the UK 2000–2010; a report by the British Artificial Nutrition Survey (BANS), a committee of BAPEN (The British Association for Parenteral and Enteral Nutrition). Available at: http://www.bapen.org.uk.
95. Stryker J. Bartholomew M. (1986) Failure of lactose-restricted diets to prevent radiation-induced diarrhea in patients undergoing whole pelvis irradiation. Int J Radiat Oncol Biol Phys 12: 789–792.
96. Sugarbaker P. (1983) Intrapelvic prosthesis to prevent injury of the small intestine with high dosage pelvic irradiation. Surg Gynecol Obstetrics 157: 269–271.
97. Theis V. Sripadam R. Ramani V. Lal S. (2010) Chronic radiation enteritis. Clin Oncol 22: 70–83.
98. Toyoda H. Jaramillo E. Mukai K. Saito T. Imai N. Naota H. et al. (2004) Treatment of radiation-induced hemorrhagic duodenitis with argon plasma coagulation. Endoscopy 36: 192.
99. Urbancsek H. Kazar T. Mezes I. Neumann K. (2001) Results of a double-blind, randomised study to evaluate the efficacy and safety of Antibiophilus in patients with radiation-induced diarrhoea. Eur J Gastroenterol Hepatol 13: 391–396.
100. Vidal-Casariego A. Calleja-Fernández A. de Urbina-González J. Cano-Rodríguez I. Cordido F. Ballesteros-Pomar M. (2013) Efficacy of glutamine in the prevention of acute radiation enteritis: a randomized controlled trial. JPEN [ePub ahead of print].
101. Waddell B. Rodriguez-Bigas M. Lee R. Weber T. Petrelli N. (1999) Prevention of chronic radiation enteritis. J Am Coll Surg 189: 611–624.
102. Wadler S. Benson A. Engelking C. Catalano R. Field M. Kornblau S. et al. (1998) Recommended guidelines for the treatment of chemotherapy-induced diarrhea. J Clin Oncol 16: 3169–3178.
103. Wedlake L. Shaw C. Whelan K. Andreyev H. (2013) Systematic review: the efficacy of nutritional interventions to counteract acute gastrointestinal toxicity during therapeutic pelvic radiotherapy. Aliment Pharmacol Therapeut 37: 1046–1056.
104. Wedlake L. Silia F. Benton B. Lalji A. Thomas K. Dearnaley D. et al. (2012) Evaluating the efficacy of statins and ACE-inhibitors in reducing gastrointestinal toxicity in patients receiving radiotherapy for pelvic malignancies. Eur J Cancer 48: 2117–2124.
105. Wedlake L. Thomas K. Lalji A. Anagnostopoulos C. Andreyev H. (2009) Effectiveness and tolerability of colesevelam hydrochloride for bile-acid malabsorption in patients with cancer: a retrospective chart review and patient questionnaire. Clin Therapeut 31: 2549–2558.
106. Widmark A. Fransson P. Tavelin B. (1994) Self-assessment questionnaire for evaluating urinary and intestinal late side effects after pelvic radiotherapy in patients with prostate cancer compared with an age-matched control population. Cancer 74: 2520–2532.
107. Wiesendanger-Wittmer E. Sijtsema N. Muijs C. Beukema J. (2012) Systematic review of the role of a belly board device in radiotherapy delivery in patients with pelvic malignancies. Radiother Oncol 102: 325–334.
108. Wong M. Lim J. Ho K. Ooi B. Tang C. Eu K. (2010) Radiation proctitis: a decade's experience. Singapore Med J 51: 315–319.
109. Yavas C. Yavas G. Acar H. Toy H. Yuce D. Akyurek S. et al. (2013) Amelioration of radiation-induced acute inflammation and mucosal atrophy by beta-hydroxy-beta-methylbutyrate, L-glutamine, and L-arginine: results of an experimental study. Supportive Care Cancer 21: 883–888.
110. Yavuz M. Yavuz A. Aydin F. Can G. Kavgaci H. (2002) The efficacy of octreotide in the therapy of acute radiation-induced diarrhea: a randomized controlled study. Int J Radiat Oncol Biol Phys 54: 195–202.
111. Yeoh E. Horowitz M. Russo A. Muecke T. Robb T. Chatterton B. (1993) Gastrointestinal function in chronic radiation enteritis - effects of loperamide-N-oxide. Gut 34: 476–482.